Brian P. Rubin

Active 1998–2025

138
Papers
26,059
Citations
83
h-index
135
i10-index

Citations

Citations per year for Brian P. Rubin1992: 1 citations1996: 1 citations1999: 2 citations2000: 13 citations2001: 52 citations2002: 78 citations2003: 141 citations2004: 185 citations2005: 173 citations2006: 155 citations2007: 160 citations2008: 199 citations2009: 193 citations2010: 176 citations2011: 162 citations2012: 177 citations2013: 168 citations2014: 159 citations2015: 163 citations2016: 154 citations2017: 167 citations2018: 142 citations2019: 586 citations2020: 624 citations2021: 747 citations2022: 540 citations2023: 356 citations2024: 577 citations2025: 186 citations2026: 4 citations1993–1995: no citations, so these years are not shown1997–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,706 citing papers, 32.3% of this breakdownChina: 687 citing papers, 8.2% of this breakdownUnited Kingdom: 488 citing papers, 5.8% of this breakdownItaly: 437 citing papers, 5.2% of this breakdownGermany: 430 citing papers, 5.1% of this breakdownCanada: 368 citing papers, 4.4% of this breakdownFrance: 355 citing papers, 4.2% of this breakdownJapan: 295 citing papers, 3.5% of this breakdownNetherlands: 253 citing papers, 3% of this breakdownSpain: 205 citing papers, 2.5% of this breakdownSwitzerland: 185 citing papers, 2.2% of this breakdownAustralia: 153 citing papers, 1.8% of this breakdown
0%32.3%Other 21.8%

Fields

  • Medicine65.1%
  • Biochemistry, Genetics and Molecular Biology25.8%
  • Computer Science3.3%
  • Immunology and Microbiology1.9%
  • Dentistry1.8%
  • Engineering0.5%
  • Other1.6%

Topics

  • Sarcoma Diagnosis and Treatment8.1%
  • Gastrointestinal Tumor Research and Treatment5.6%
  • Gastrointestinal disorders and treatments2.7%
  • Cancer Genomics and Diagnostics2.4%
  • Soft tissue tumor case studies2%
  • Vascular Tumors and Angiosarcomas1.8%
  • Other77.4%

Coauthors

All papers

Open in search
  1. Functional Enhancers Shape Extrachromosomal Oncogene Amplifications

    Authors: , , , , , , , , , , , , , , , , , , - Cell 2019 cited by 369

  2. Therapeutic targeting of TEAD transcription factors in cancer

    Authors: , , , - Trends in Biochemical Sciences 2023 cited by 141

  3. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells

    Authors: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2006 cited by 560

  4. Whole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical Pathology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark R. Wick, Ji Yoon, Po Zhao, Clive R. Taylor - The American Journal of Surgical Pathology 2017 cited by 396

  5. Identification of a Disease-Defining Gene Fusion in Epithelioid Hemangioendothelioma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2011 cited by 401

  6. Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rebecca A. Gladdy, F. Gouin, Giovanni Grignani, J. Gutkovich, Rick L. Haas, Nadia Hindi, Peter Hohenberger, Paul H. Huang, Heikki Joensuu, Robin L. Jones, Christiane Jungels, Bernd Kasper, Akira Kawai, Axel Le Cesne, Franel Le Grange, Andreas Leithner, Hugh Leonard, A. Lopez Pousa, Javier Martín‐Broto, Ofer Merimsky, Priscilla Merriam, Rosalba Miceli, Olivier Mir, Michele Molinari, Michael Montemurro, Graziano Oldani, Emanuela Palmerini, Maria A. Pantaleo, S. Patel, Sophie Piperno‐Neumann, Chandrajit P. Raut, Vinod Ravi, Albiruni R. Abdul Razak, Peter Reichardt, Brian P. Rubin, Piotr Rutkowski, Akmal Safwat, Claudia Sangalli, Gonzalo Sapisochín, Marta Sbaraglia, S. Scheipl, Patrick Schöffski, D. Strauß, Sandra J. Strauss, Kirsten Sundby Hall, William D. Tap, Annalisa Trama, Andrew Tweddle, Winette T.A. van der Graaf, Michiel A. J. van de Sande, Winan J. van Houdt, G. van Oortmerssen, Andrew J. Wagner, Markus Wartenberg, Jayne Wood, Nadia Zaffaroni, Camilla Zimmermann, Paolo G. Casali, Angelo Paolo Dei Tos, Alessandro Gronchi - ESMO Open 2021 cited by 183

  7. The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Science 2016 cited by 280

  8. Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

    Authors: , , , , , , , , , , , , , , , , , , - British Journal of Cancer 2019 cited by 166

  9. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases

    Authors: , , , , , , , , , , , , , , , , , , , , , - Modern Pathology 2021 cited by 74

  10. NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mary Anne Bergman, Giby V. George - Journal of the National Comprehensive Cancer Network 2020 cited by 303

  11. NSD3–NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism

    Authors: , , , , , , , , , , , , - Cancer Discovery 2014 cited by 246

  12. Diagnosis of known sarcoma fusions and novel fusion partners by targeted RNA sequencing with identification of a recurrent ACTB-FOSB fusion in pseudomyogenic hemangioendothelioma

    Authors: , , , , , , , , , , , , - Modern Pathology 2018 cited by 167

  13. Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nadine Otten, Emanuela Palmerini, Shreyaskumar Patel, Peter Reichardt, Brian P. Rubin, Piotr Rutkowski, Claudia Sangalli, Kathrin Schuster, Beatrice Seddon, Morena Shkcodra, Eric L. Staals, William D. Tap, Matt van de Rijn, Kirsten van Langevelde, Filip M.M. Vanhoenacker, Andrew J. Wagner, Lisette M. Wiltink, Sydney Stern, Michiel A. J. van de Sande, Sebastian Bauer - Cancer Treatment Reviews 2022 cited by 108

  14. WWTR1(TAZ)-CAMTA1 gene fusion is sufficient to dysregulate YAP/TAZ signaling and drive epithelioid hemangioendothelioma tumorigenesis

    Authors: , , , , , , , - Genes & Development 2021 cited by 71

  15. Diagnosis of gastrointestinal stromal tumors: A consensus approach

    Authors: , , , , , , , , , , , , - Human Pathology 2002 cited by 3,454

  16. Gastrointestinal stromal tumour

    Authors: , , - The Lancet 2007 cited by 1,043

  17. KIT Gene Mutations and Copy Number in Melanoma Subtypes

    Authors: , , , , , , , , , , , , , , - Clinical Cancer Research 2008 cited by 636

  18. Identification of recurrent SMO and BRAF mutations in ameloblastomas

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2014 cited by 361

  19. Alpha to Omicron: Disease Severity and Clinical Outcomes of Major SARS-CoV-2 Variants

    Authors: , , , , , , , , , , , , - The Journal of Infectious Diseases 2022 cited by 155

  20. Positively selected enhancer elements endow osteosarcoma cells with metastatic competence

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 173

  21. Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials

    Authors: , , , , , , , , , , , , - Journal of Clinical Oncology 2010 cited by 401

  22. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival

    Authors: , , , , , , , , , , , , , - Modern Pathology 2016 cited by 248

  23. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein

    Authors: , , , , , , - Oncogene 2015 cited by 118

  24. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile

    Authors: , , , , , - Modern Pathology 2021 cited by 69